Islatravir (MK-8591)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Islatravir (MK-8591), covering 2018-12-03 to 2023-03-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016) [Phase 2]